ASE · Financial Statements

InfuSystems Holdings, Inc. (INFU) Financial Statements

$13.94 ASE: INFU Market Cap $277.65M

InfuSystems Holdings, Inc. most recently reported annual revenue of $143.0M, net profit of $7.0M. Revenue grew at an average annual rate of 8.1% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

InfuSystems Holdings, Inc.: Revenue rose from $70.0M in 2016 to $143.0M in 2025, a change of +104.3% over 9 years; net profit was positive in 6 of 10 reported years; operating margin moved from 1.4% to 8.3%, a shift of +6.9 percentage points; the most recent year shows net profit of $7.0M.

Income Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Revenue$70.0M$71.0M$67.0M$81.0M$97.0M$102.0M$110.0M$126.0M$135.0M$143.0M
Operating Expenses$70.0M$75.0M$67.0M$78.0M$89.0M$100.0M$108.0M$122.0M$128.0M$132.0M
Operating Profit$1.0M$-4.0M$0$4.0M$9.0M$3.0M$2.0M$4.0M$7.0M$12.0M
Operating Margin1.4%-5.4%0.6%4.3%9.1%2.8%1.5%3.3%5.1%8.3%
Other Income$-1.0M$-1.0M$-1.0M$-2.0M$-1.0M$-2.0M$-2.0M$-2.0M$-2.0M$-1.0M
Interest$1.0M$1.0M$1.0M$2.0M$1.0M$1.0M$1.0M$2.0M$2.0M$1.0M
Depreciation$11.0M$13.0M$11.0M$12.0M$14.0M$15.0M$13.0M$13.0M$12.0M$13.0M
Profit Before Tax$0$-5.0M$-1.0M$2.0M$8.0M$1.0M$0$2.0M$5.0M$11.0M
Tax$39.0M$-293.9M$-5.1M$10.7M$-129.8M$-13.0M$86.2M$52.9M$53.6M$37.6M
Net Profit$0$-21.0M$-1.0M$1.0M$17.0M$1.0M$0$1.0M$2.0M$7.0M
EPS$-0.01$-0.91$-0.05$0.07$0.80$0.06$0.00$0.04$0.11$0.31
Dividend Payout0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricSep '23Dec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26
Revenue$32.0M$32.0M$32.0M$34.0M$35.0M$34.0M$35.0M$36.0M$36.0M$36.0M$34.0M$37.0M
Operating Expenses$30.0M$31.0M$33.0M$32.0M$32.0M$31.0M$34.0M$32.0M$33.0M$33.0M$32.0M$33.0M
Operating Profit$2.0M$1.0M$-1.0M$2.0M$3.0M$3.0M$1.0M$4.0M$4.0M$4.0M$2.0M$4.0M
Operating Margin5.3%3.9%-2.6%5.5%9.2%7.7%1.8%10.5%10.4%10.3%4.7%11.2%
Interest$1.0M$1.0M$0$0$0$0$0$0$0$0$0$0
Profit Before Tax$1.0M$1.0M$-1.0M$1.0M$3.0M$2.0M$0$3.0M$3.0M$3.0M$1.0M$4.0M
Tax$38.5M$90.1M$14.3M$45.2M$35.1M$58.8M$205.5M$24.6M$34.1M$41.8M$28.2M$16.5M
Net Profit$1.0M$0$-1.0M$1.0M$2.0M$1.0M$0$3.0M$2.0M$2.0M$1.0M$3.0M
EPS$0.03$0.00$-0.05$0.03$0.08$0.04$-0.01$0.12$0.11$0.10$0.05$0.15

Over the 10 years reported for InfuSystems Holdings, Inc., borrowings decreased from $37.0M in 2016 to $3.0M in 2025, cash stood at $3.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 1.80 times.

Balance Sheet — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Total Assets$96.0M$69.0M$64.0M$79.0M$97.0M$98.0M$99.0M$103.0M$104.0M$101.0M
Current Assets$21.0M$18.0M$18.0M$19.0M$30.0M$22.0M$25.0M$31.0M$32.0M$36.0M
Cash$3.0M$3.0M$4.0M$3.0M$10.0M$0$0$0$1.0M$3.0M
Inventory$2.0M$2.0M$2.0M$3.0M$3.0M$4.0M$5.0M$6.0M$7.0M$5.0M
Receivables$12.0M$11.0M$10.0M$12.0M$15.0M$15.0M$17.0M$20.0M$21.0M$23.0M
Fixed Assets$30.0M$25.0M$25.0M$43.0M$44.0M$49.0M$48.0M$46.0M$9.0M$8.0M
Capital Work in Progress$0$0$0$0$0$0$0$0$0$0
Investments$0$0$0$0$0$42.0M$44.0M$0$45.0M$0
Other Assets$0$0$0$0$0$4.0M$4.0M$4.0M$4.0M$4.0M
Total Liabilities$46.0M$38.0M$44.0M$57.0M$56.0M$49.0M$51.0M$51.0M$46.0M$43.0M
Current Liabilities$16.0M$12.0M$15.0M$22.0M$23.0M$13.0M$14.0M$16.0M$18.0M$20.0M
Borrowings$37.0M$29.0M$34.0M$43.0M$43.0M$37.0M$37.0M$35.0M$28.0M$3.0M
Other Liabilities$8.0M$8.0M$10.0M$14.0M$14.0M$13.0M$14.0M$16.0M$18.0M$40.0M
Equity$0$0$0$0$0$0$0$0$0$0
Reserves$51.0M$31.0M$20.0M$22.0M$41.0M$48.0M$48.0M$52.0M$58.0M$57.0M

For InfuSystems Holdings, Inc., operating cash flow was positive in 10 of 10 reported years; free cash flow in the latest year was $16.0M; free cash flow was positive in 7 of 10 years; financing activities used $11.0M in the latest year, which covers debt repayment, dividends and buybacks.

Cash Flow Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Operating Cash Flow$8.0M$8.0M$11.0M$14.0M$20.0M$18.0M$18.0M$11.0M$20.0M$24.0M
Investing Cash Flow$-14.0M$1.0M$-10.0M$-42.0M$-29.0M$-38.0M$-27.0M$-18.0M$-31.0M$-15.0M
Financing Cash Flow$0$0$-10.0M$0$-2.0M$-1.0M$-6.0M$0$-2.0M$-11.0M
Net Cash Flow$3.0M$0$1.0M$-2.0M$7.0M$-9.0M$0$0$0$3.0M
Free Cash Flow$-1.0M$4.0M$3.0M$-9.0M$3.0M$2.0M$2.0M$0$3.0M$16.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.38
EV / EBITDA12.61
FCF Yield7.19%
Quick Ratio2.14
Interest Coverage18.38
Return 1Y63.81%
Return 3Y-9.72%
Return 5Y-50.22%

InfuSystems Holdings, Inc. (INFU) financials — frequently asked questions

What is InfuSystems Holdings, Inc.'s annual revenue?

InfuSystems Holdings, Inc. (INFU) reported annual revenue of $143.0M in its most recent fiscal year.

What is InfuSystems Holdings, Inc.'s net profit?

InfuSystems Holdings, Inc. (INFU) reported net profit of $7.0M in its most recent fiscal year.

What is INFU EV/EBITDA?

InfuSystems Holdings, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is 12.61.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
INFU Overview INFU Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.